This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2022 financial results on Thursday, April...
Positivity for Cocaine and Marijuana Increase for Federally Mandated, Safety-Sensitive Workers Required to Test Under Federal Law Amid Widespread Recruiting and Retention Challenges, Drug...
Quest to employ its comprehensive menu of COVID-19 antibody test and data analytics services to support population health research across 45 states and Puerto Rico SECAUCUS, N.J., March 23, 2022...
The Quest Diagnostics Foundation today announced a $500,000 donation to Project HOPE to support its humanitarian crisis relief efforts in Ukraine and for Ukrainian refugees in Eastern Europe....
At Quest Diagnostics, our vision is “Empowering better health with diagnostic insights.” Our goal is to make this a healthier world – not just for some, but for all. As we near the two-year...
Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three states
Bronx, N.Y./Secaucus, N.J, Feb. 15, 2022: Green Bronx Machine, a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences, today...
-- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive Chairman
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its Board of Directors, as part of its ongoing leadership succession planning,...
- Full year revenues of $10.79 billion, up 14.3% from 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022...
Convenient, physician-guided medical insights help people manage health without a trip to the doctor's office
Quest Diagnostics (NYSE: DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to...
